100 Gati Shakti Cargo Terminal to be developed till 2025
Supply Chain

100 Gati Shakti Cargo Terminal to be developed till 2025

22 GCTs have already been commissioned whereas 125 applications for development of cargo terminals under the GCT Policy have been received and 79 in-principle approvals have been granted

  • By ICN Bureau | December 08, 2022

Under the Gati Shakti Cargo Terminal (GCT) Policy, it has been targeted to develop 100 GCTs in three years i.e. 2022-23, 2023-24 & 2024-25 says Minister of Railways, Communications and Electronic & Information Technology, Ashwini Vaishnaw in a written reply to a question in Lok Sabha. 

22 GCTs have already been commissioned whereas 125 applications for development of cargo terminals under the GCT Policy have been received and 79 in-principle approvals have been granted.

For GCTs to be developed on non-Railway land, the GCT operators will identify the location and will construct the terminal after obtaining necessary approval. For GCTs to be developed either fully or partially on Railway land, the land parcels will be identified by Railways, and the GCT Operator for construction and operation of the terminal will be selected through open tendering process.

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Chemical

Petrochemical

Energy

Digitization

Aim to become import substitute for instrumentation business in India
Aim to become import substitute for instrumentation business in India
Vinayak M. Patankar, Sreejith Kumar Whole Time Director & CEO, Borosil Scientific Ltd. , Associate Vice President - Design, Borosil Scientific Ltd.

Looking at increasing manufacturing base outside India
Looking at increasing manufacturing base outside India
Sidharth A. Choksi Executive Vice President, Hindustan Platinum Pvt. Ltd

Developing new products like Vitamin B1 and Vitamin B6
Developing new products like Vitamin B1 and Vitamin B6
Hemal Mehta, Sachin Mehta Chairman, Sudarshan Pharma Industries Ltd. & Managing Director, Sudarshan Pharma Industries Ltd.